Keyphrases
Acute Myeloid Leukemia
14%
Atypical Hemolytic Uremic Syndrome (aHUS)
14%
Autoimmunity
14%
Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE)
14%
Belgian
14%
CD46
14%
CHRNA4
14%
Co-produced
14%
Confidence Interval
13%
Congenital Mirror Movements
14%
Cytogenetically Normal Acute Myeloid Leukemia
28%
Defect Association
14%
Denmark
7%
Dutch
14%
Energy Metabolism
14%
Focal Dermal Hypoplasia
14%
Genotype Prevalence
14%
Gorlin Syndrome
14%
GREB1L
14%
Hong Kong
14%
Interview Study
14%
Isoform Expression
14%
Juvenile-onset
14%
KBG Syndrome
28%
Leukemia Progression
14%
Lived Experience
14%
Microdeletion
14%
Monozygotic Triplets
14%
Mutational Landscape
14%
Natural History
14%
Novel Candidate Genes
14%
Nucleophosmin 1 (NPM1)
10%
Patient Caregivers
14%
Pediatric Hematology
14%
Prevalence Estimation
16%
Proteomic Analysis
14%
PTPRM
14%
Relapsed Disease
14%
Renal Agenesis
14%
Rokitansky Syndrome
28%
Seizure
8%
Self-reported Experience
14%
Sexual Well-being
14%
Single Center
14%
Three-generation Family
14%
Tracheoesophageal Fistula
14%
Vaginal Agenesis
14%
Vaginoplasty
14%
Vertebral Defects
14%
Whole Exome Sequencing
14%
Medicine and Dentistry
Acute Myelogenous Leukemia
14%
Acute Myeloid Leukemia
42%
Agenesis
5%
Aplasia
9%
Ascending Aorta
7%
Autoimmunity
7%
Autosomal Dominant Inheritance
14%
Cardiovascular System
7%
CHRNA4
14%
Clinical Feature
7%
Comorbidity
28%
Congenital Malformation
7%
Epileptic Seizure
33%
Esophageal Atresia
14%
Event Free Survival
7%
Familial Disease
14%
Focal Dermal Hypoplasia
14%
Gene Expression Profiling
14%
Genetic Screening
8%
Haploinsufficiency
7%
Imperforate Anus
14%
Karyotype
14%
Limb Defect
14%
Medical Care
7%
Overall Survival
5%
Pediatric Hematology
14%
Personal Experience
14%
Polygenic Risk Score
14%
Prevalence
31%
Proteogenomics
14%
Rokitansky Syndrome
100%
Seizure Types
7%
Self Concept
7%
Tracheoesophageal Fistula
14%
Treatment Response
7%
Tricho-Rhino-Phalangeal Syndrome
14%
Vagina Aplasia
15%
Vagina Reconstruction
14%
Biochemistry, Genetics and Molecular Biology
Autoimmunity
21%
Autosomal Dominant Inheritance
20%
C3b
14%
Candidate Gene
28%
CD46
14%
CHRNA4
14%
Comorbidity
28%
Dilatation
7%
Emotions
14%
Energy Metabolism
14%
Event Free Survival
7%
Exome Sequencing
16%
Gene Expression Profiling
14%
Genetic Counseling
7%
Genetic Screening
8%
Haploinsufficiency
9%
HNF1B
7%
Isoform
14%
Karyotype
28%
Karyotype 46,XX
7%
LHX1
7%
Mental Retardation
9%
Missense
9%
Myeloid
71%
NPM1
9%
Offspring
7%
Overall Survival
5%
PAX8
7%
Pedigree
9%
Penetrance
8%
Personal Experience
14%
Polygenic Score
14%
Prevalence
24%
Proteogenomics
14%
RAD51
14%
STAT3
9%
Thematic Analysis
14%
Tricho-Rhino-Phalangeal Syndrome Type 1
14%
WT1
5%